Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T CellsMatthew J. Frigault, Carl H. June, Ji‐Hyun Lee et al.|Cancer Immunology Research|2015Cited by 332
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durabilitySònia Guedan, Avery D. Posey|Journal of Clinical Investigation|2020Cited by 195
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P. Patel, Patrizia Porazzi, Steven Yang et al.|Science Immunology|2024Cited by 45
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphomaKeisuke Watanabe, Carl H. June, Angela M. Gomez et al.|Blood Advances|2023Cited by 43
Voices of biotech researchNasim Annabi, Jianbin Wang, Matthew A. B. Baker et al.|Nature Biotechnology|2021Cited by 3